音量 1, 問題 9 (2011)
治療の見通し
Chemoprevention of prostate cancer: is there evidence from clinical trials?
Marcelo Langer Wroclawski, Cynthia Kuk, Antonio Finelli, Neil E Fleshner, Alexandre R Zlotta
治療の見通し
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
総説
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
総説
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
総説
Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress
Monica Millan, Antoni Davalos
臨床試験の結果
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
議事録
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
臨床試験の結果
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
